The ProTide prodrug technology has proved very useful in the discovery of nucleotide therapeutics and has successfully led to two FDA-approved drugs. However, with the extensive application of this prodrug approach to nucleotides for nearly three decades, the intellectual property (IP) landscape is becoming congested and, to overcome this, new inventive applications of the ProTide prodrug technology are emerging
One in seven approved anticancer drugs in the UK are nucleoside analogues (NA). However, frequent de...
The phosphoroamidate (ProTide) approach is a prodrug technology aimed to circumvent metabolic bottl...
Nonsymmetric DiPPro-nucleotides are described as nucleoside diphosphate (NDP) delivery systems. The ...
The ProTide prodrug technology has proved very useful in the discovery of nucleotide therapeutics an...
The ProTide technology is a prodrug approach developed for the efficient intracellular delivery of ...
The masking of nucleoside phosphate and phosphonate groups by an aryl motif and an amino acid ester,...
Introduction: The ProTide technology is a phosphate (or phosphonate) prodrug method devised to deliv...
Cancer and viral infections such as hepatitis B infection and acquired immune deficiency syndrome (A...
Intracellular phosphorylation of therapeutic nucleoside analogues into their active triphosphate met...
Nucleoside monophosphates and monophosphonates have been known for a long time to exert favorable ph...
Following the first report on the nucleoside phosphoramidate (ProTide) prodrug approach in 1990 by C...
Cancer is one the on the leading causes of mortality in world, causing 8.2 million deaths in 2012. ...
Phosphoramidate pro-nucleotides (ProTides) have revolutionized the field of anti-viral and anti-canc...
Background: The design and development of prodrugs is the most common and e ective strategy to over...
One in seven approved anticancer drugs in the UK are nucleoside analogues (NA). However, frequent de...
The phosphoroamidate (ProTide) approach is a prodrug technology aimed to circumvent metabolic bottl...
Nonsymmetric DiPPro-nucleotides are described as nucleoside diphosphate (NDP) delivery systems. The ...
The ProTide prodrug technology has proved very useful in the discovery of nucleotide therapeutics an...
The ProTide technology is a prodrug approach developed for the efficient intracellular delivery of ...
The masking of nucleoside phosphate and phosphonate groups by an aryl motif and an amino acid ester,...
Introduction: The ProTide technology is a phosphate (or phosphonate) prodrug method devised to deliv...
Cancer and viral infections such as hepatitis B infection and acquired immune deficiency syndrome (A...
Intracellular phosphorylation of therapeutic nucleoside analogues into their active triphosphate met...
Nucleoside monophosphates and monophosphonates have been known for a long time to exert favorable ph...
Following the first report on the nucleoside phosphoramidate (ProTide) prodrug approach in 1990 by C...
Cancer is one the on the leading causes of mortality in world, causing 8.2 million deaths in 2012. ...
Phosphoramidate pro-nucleotides (ProTides) have revolutionized the field of anti-viral and anti-canc...
Background: The design and development of prodrugs is the most common and e ective strategy to over...
One in seven approved anticancer drugs in the UK are nucleoside analogues (NA). However, frequent de...
The phosphoroamidate (ProTide) approach is a prodrug technology aimed to circumvent metabolic bottl...
Nonsymmetric DiPPro-nucleotides are described as nucleoside diphosphate (NDP) delivery systems. The ...